Positioning patient face-down could improve chances of macula hole closure

Article

Positioning patients face down after surgery could improve chances of macula hole closure

Positioning patients face down after surgery could improve chances of macula hole closure, according to a study in the journal Eye.

The randomized, controlled trial, led by Dr J. Bainbridge, included 30 phakic eyes of 30 subjects with idiopathic full-thickness macula holes. Each patient underwent vitrectomy with dye-assisted peeling of the ILM and 14% perfluoropropane gas.

Participants were randomized into two groups. Group 1, the posturing group, were positioned face-down for 10 days and group 2, the non-posturing group, were to avoid a face-up position. The primary measure was anatomical macula hole closure.

The results revealed that macula holes closed in 14 of the 15 eyes in group 1 and in 9 of 15 eyes in group 2. Macula holes smaller than 400μm closed regardless of posturing. In 10 of the 11 remaining group 1 eyes holes larger than 400μm closed and 4 of 10 eyes in group 2.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.